Australia markets closed

Dr Reddy's Laboratories Ltd (RDDA.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
67.00+1.00 (+1.52%)
At close: 08:04AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Total revenue
279,164,000
279,164,000
245,879,000
214,391,000
189,722,000
Cost of revenue
115,557,000
115,557,000
106,536,000
100,551,000
86,645,000
Gross profit
163,607,000
163,607,000
139,343,000
113,840,000
103,077,000
Operating expenses
Research development
22,873,000
22,873,000
19,381,000
17,482,000
16,541,000
Selling general and administrative
77,201,000
77,201,000
68,026,000
62,081,000
54,650,000
Total operating expenses
98,299,000
98,299,000
80,289,000
77,921,000
70,167,000
Operating income or loss
65,308,000
65,308,000
59,054,000
35,919,000
32,910,000
Interest expense
1,711,000
1,711,000
1,428,000
958,000
970,000
Total other income/expenses net
5,995,000
5,995,000
1,561,000
-3,628,000
-6,353,000
Income before tax
71,870,000
71,870,000
60,367,000
32,298,000
26,413,000
Income tax expense
16,186,000
16,186,000
15,300,000
8,730,000
9,175,000
Income from continuing operations
55,684,000
55,684,000
45,067,000
23,568,000
17,238,000
Net income
55,684,000
55,684,000
45,067,000
23,568,000
17,238,000
Net income available to common shareholders
55,684,000
55,684,000
45,067,000
23,568,000
17,238,000
Basic EPS
306.20
335.22
271.47
142.08
115.47
Diluted EPS
305.55
334.59
270.90
141.69
115.14
Basic average shares
166,178
166,395
166,033
165,878
165,835
Diluted average shares
166,530
166,709
166,382
166,335
166,311